Cidara Therapeutics (NASDAQ:CDTX) Stock Rating Upgraded by StockNews.com
Cidara Therapeutics (NASDAQ:CDTX – Get Free Report) was upgraded by equities research analysts at StockNews.com to a “sell” rating in a research report issued on Saturday. Other research analysts have also issued research reports about the stock. Citizens Jmp initiated coverage on shares of Cidara Therapeutics in a research report on Wednesday, March 12th. They […]
Cidara Therapeutics (NASDAQ:CDTX – Get Free Report) was upgraded by equities research analysts at StockNews.com to a “sell” rating in a research report issued on Saturday. Other research analysts have also issued research reports about the stock. Citizens Jmp initiated coverage on shares of Cidara Therapeutics in a research report on Wednesday, March 12th. They […]
